Controlling Tissue Microenvironments: Biomimetics, Transport Phenomena, and Reacting Systems |
|
|
R.J. Fisher, R.A. Peattie |
|
|
1 | |
|
|
3 | |
|
1.1 Overview and Motivation |
|
|
3 | |
|
1.2 Background and Approach |
|
|
4 | |
|
2 Tissue Microenvironments |
|
|
6 | |
|
2.1 Specifying Performance Criteria |
|
|
6 | |
|
2.2 Estimating Tissue Function |
|
|
6 | |
|
2.2.1 Blood Microenvironment |
|
|
6 | |
|
2.2.2 Bone Marrow Microenvironment |
|
|
7 | |
|
|
8 | |
|
2.3.1 Cellular Communication Within Tissues |
|
|
8 | |
|
2.3.2 Soluble Growth Factors |
|
|
9 | |
|
2.3.3 Direct Cell-to-Cell Contact |
|
|
9 | |
|
2.3.4 Extracellular Matrix and Cell-Tissue Interactions |
|
|
10 | |
|
2.3.5 Communication with the Whole Body Environment |
|
|
11 | |
|
|
12 | |
|
|
13 | |
|
|
14 | |
|
|
14 | |
|
2.7.1 Compartmental Analysis |
|
|
15 | |
|
2.7.2 Blood-Brain Barrier |
|
|
26 | |
|
2.7.3 Cell Culture Analog (CCA): Animal Surrogate System |
|
|
28 | |
|
|
30 | |
|
3.1 Fundamentals of Biomimicry |
|
|
30 | |
|
3.1.1 Morphology and Properties Development |
|
|
31 | |
|
3.1.2 Molecular Engineering |
|
|
31 | |
|
3.1.3 Biotechnology and Engineering Biosciences |
|
|
32 | |
|
3.2 Biomimetic Membranes: Ion Transport |
|
|
32 | |
|
3.2.1 Active Transport Biomimetics |
|
|
33 | |
|
3.2.2 Facilitated Transport via Fixed Carriers |
|
|
34 | |
|
3.2.3 Facilitated Transport via Mobile Carriers |
|
|
34 | |
|
|
35 | |
|
3.3.1 Uncoupling Mass Transfer Resistances |
|
|
35 | |
|
3.3.2 Pharmacokinetics and CCA Systems |
|
|
35 | |
|
3.4 Electron Transfer Chain Biomimetics |
|
|
37 | |
|
3.4.1 Mimicry of In Vivo Coenzyme Regeneration |
|
|
37 | |
|
3.4.2 Electro-Enzymatic Membrane Bioreactors |
|
|
38 | |
|
3.5 Biomimicry and the Vascular System |
|
|
38 | |
|
3.5.1 Hollow Fiber Systems |
|
|
39 | |
|
3.5.2 Pulsatile Flow in Biomimetic Blood Vessels |
|
|
40 | |
|
3.5.3 Abdominal Aortic Aneurysm Emulation |
|
|
43 | |
|
3.5.4 Stimulation of Angiogenesis with Biomimetic Implants |
|
|
45 | |
|
|
46 | |
|
|
47 | |
|
4.1.1 Membrane Physical Parameters |
|
|
49 | |
|
|
49 | |
|
4.1.3 Dextran Diffusivity |
|
|
50 | |
|
4.1.4 Marker Molecule Diffusivity |
|
|
51 | |
|
4.1.5 Interpreting Experimental Results |
|
|
53 | |
|
|
53 | |
|
4.2.1 Models of Perfused Tissues: Continuum Approach |
|
|
54 | |
|
4.2.2 Alternative Approaches |
|
|
55 | |
|
|
56 | |
|
|
58 | |
|
5.1 Metabolic Pathway Studies: Emulating Enzymatic Reactions |
|
|
58 | |
|
|
61 | |
|
|
61 | |
|
5.2.2 Design of Microreactors |
|
|
63 | |
|
|
64 | |
|
5.2.4 Performance and Operational Maps |
|
|
64 | |
|
|
65 | |
|
6 Capstone Illustration: Control of Hormone Diseases via Tissue Therapy |
|
|
66 | |
|
6.1 Selection of Diabetes as Representative Case Study |
|
|
66 | |
|
6.2 Encapsulation Motif: Specifications and Design |
|
|
67 | |
|
|
70 | |
Perfusion Effects and Hydrodynamics |
|
|
R.A. Peattie, R.J. Fisher |
|
|
75 | |
|
|
76 | |
|
1.1 Overview and Motivation |
|
|
76 | |
|
1.2 Background and Approach |
|
|
79 | |
|
2 Elements of Theoretical Hydrodynamics |
|
|
79 | |
|
2.1 Mathematical Preliminaries |
|
|
80 | |
|
2.2 Elements of Continuum Mechanics |
|
|
83 | |
|
2.2.1 Constitutive Equations |
|
|
86 | |
|
2.2.2 Conservation (Field) Equations |
|
|
88 | |
|
2.2.3 Turbulence and Instabilities |
|
|
92 | |
|
|
96 | |
|
2.3.1 Steady Poiseuille Flow |
|
|
97 | |
|
|
102 | |
|
2.3.3 Mechanical Energy Equation |
|
|
105 | |
|
3 Models and Computational Techniques |
|
|
109 | |
|
3.1 Approximations to the Navier-Stokes Equations |
|
|
109 | |
|
3.2 Computational Fluid Dynamics (CFD) |
|
|
110 | |
|
3.2.1 Theory and Software Packages |
|
|
111 | |
|
3.2.2 Predicting Surface and Interfacial Phenomena |
|
|
113 | |
|
3.2.3 Predicting Biomimetic Reactor Performance |
|
|
116 | |
|
|
116 | |
|
|
119 | |
|
4.1 Design Specifications |
|
|
119 | |
|
4.2 Devices and Performance |
|
|
120 | |
|
4.3 Stress Effects on Cellular Viability and Function |
|
|
124 | |
|
5 Flow Patterns, Mixing and Transport Phenomena |
|
|
126 | |
|
|
127 | |
|
5.2 Extra-Corporeal Systems |
|
|
128 | |
|
|
128 | |
|
5.2.2 Blood Detoxification |
|
|
129 | |
|
|
131 | |
|
6.1 Hemodynamics in Rigid Tubes: Womersley's Theory |
|
|
133 | |
|
6.2 Hemodynamics in Elastic Tubes |
|
|
138 | |
|
6.3 Turbulence in Pulsatile Flow |
|
|
142 | |
|
7 Capstone Illustration: Understanding Arterial Diseases; Diagnosis and Therapy |
|
|
143 | |
|
7.1 Selection of AAA as a Representative Case Study |
|
|
145 | |
|
7.2 Coupling Tissue Engineering and Hydrodynamics |
|
|
148 | |
|
7.2.1 Clinical Evaluation of Patient Perfusion |
|
|
148 | |
|
7.2.2 Biomimetic Flow Emulation |
|
|
149 | |
|
7.2.3 Physics of Flow in Axisymmetric Bulges |
|
|
150 | |
|
7.2.4 Pulsatile Flow in Compliant Blood Vessels: Computation and Experiments |
|
|
151 | |
|
|
153 | |
Biopreservation of Cells and Engineered Tissues |
|
|
|
157 | |
|
|
158 | |
|
|
159 | |
|
2.1 Trends in in Vitro Culture |
|
|
160 | |
|
2.2 In Vitro Culture of Engineered Cells and Tissues |
|
|
161 | |
|
2.3 Limitations of in Vitro Culture |
|
|
162 | |
|
|
163 | |
|
3.1 Hypothermia-Induced Injury |
|
|
163 | |
|
3.2 Strategies for Hypothermic Storage of Cells, Tissues and Organs |
|
|
164 | |
|
3.3 Limitations of Hypothermic Storage |
|
|
165 | |
|
|
165 | |
|
4.1 Cryopreservation: Freeze-Thaw and Vitrification |
|
|
168 | |
|
4.2 Freeze-Thaw Cryopreservation |
|
|
169 | |
|
4.3 Vitrification of Cells and Tissues |
|
|
172 | |
|
4.4 Limitations of Cryopreservation |
|
|
173 | |
|
5 Desiccation and Dry Storage |
|
|
173 | |
|
5.1 Adaptive Protection from Reactive Oxygen Species |
|
|
174 | |
|
5.2 Intracellular Sugars and Desiccation Tolerance |
|
|
175 | |
|
5.3 Quiescence and Diapause |
|
|
176 | |
|
5.4 Future of Desiccation and Dry Storage |
|
|
177 | |
|
|
178 | |
|
|
179 | |
Fabrication of Three-Dimensional Tissues |
|
|
|
189 | |
|
|
190 | |
|
2 Fabrication of Three-Dimensional Acellular Scaffolds |
|
|
192 | |
|
2.1 Fabrication with Heat |
|
|
192 | |
|
2.2 Fabrication with Binders |
|
|
194 | |
|
2.3 Fabrication with Light |
|
|
195 | |
|
2.4 Fabrication by Molding |
|
|
197 | |
|
3 Fabrication of Cellular Structures |
|
|
198 | |
|
4 Fabrication of Hybrid (Cell/Scaffold) Constructs |
|
|
199 | |
|
|
199 | |
|
4.2 Three-Dimensional Photopatterning of Cell-Laden Hydrogels |
|
|
200 | |
|
|
203 | |
|
6 Future Directions in Three-Dimensional Tissue Fabrication |
|
|
204 | |
|
|
204 | |
Engineering Skin to Study Human Disease - Tissue Models for Cancer Biology and Wound Repair |
|
|
|
207 | |
|
|
208 | |
|
2 Engineered human tissue models used to study early cancer progression in stratified squamous epithelium |
|
|
211 | |
|
2.1 Cell-cell interactions inherent in 3-D tissue architecture suppress early cancer progression by inducing a state of intraepithelial dormancy |
|
|
213 | |
|
2.2 Factors altering cell-cell and cell-matrix interactions abrogate the microenvironmental control on intraepithelial tumor cells and promote cancer progression |
|
|
217 | |
|
2.2.1 The tumor promoter TPA enables expansion of intraepithelial tumor cells |
|
|
217 | |
|
2.2.2 Immortalization of adjacent epithelial cells cannot induce intraepithelial dormancy of tumor cells |
|
|
218 | |
|
2.2.3 UV-B Irradiation is permissive for tumor cell expansion by inducing a differential apoptotic and proliferative response between tumor cells and adjacent normal cells |
|
|
221 | |
|
2.2.4 Basement membrane proteins promote progression of early cancer by rescuing tumor cells from intraepithelial dormancy through their selective adhesion to laminin 1 and Type IV collagen and subsequent expansion |
|
|
223 | |
|
3 Three-dimensional skin-equivalent tissue models to study wound reepithelialization of human stratified epithelium |
|
|
227 | |
|
3.1 Morphology of wounded skin equivalents |
|
|
227 | |
|
3.2 Proliferation in skin equivalents in response to wounding |
|
|
231 | |
|
3.3 Migration in skin equivalents in response to wounding |
|
|
232 | |
|
3.4 Growth factor responsiveness and synthesis in wounded skin equivalents |
|
|
233 | |
|
3.5 Matrix metalloproteinase activity in wounded skin equivalents |
|
|
235 | |
|
3.6 Keratinocyte differentiation in wounded skin equivalents |
|
|
236 | |
|
|
237 | |
Gene-Modified Tissue-Engineered Skin: The Next Generation of Skin Substitutes |
|
|
|
241 | |
|
|
242 | |
|
2 Tissue Engineering of Skin |
|
|
243 | |
|
2.1 Skin Structure and Physiology |
|
|
243 | |
|
2.2 Tissue-Engineered Skin |
|
|
244 | |
|
2.2.1 Biomaterial Dressings |
|
|
244 | |
|
2.2.2 Cell-based Skin Substitutes |
|
|
245 | |
|
2.3 Limitations of Current Technologies |
|
|
246 | |
|
3 Gene Therapy in Tissue Engineering of Skin |
|
|
247 | |
|
|
247 | |
|
3.1.1 Gene Delivery Vehicles |
|
|
247 | |
|
3.1.2 Routes of Gene Delivery - Short- vs. Long-Term Gene Transfer |
|
|
248 | |
|
3.2 Candidate Disease Conditions for Gene Therapy of the Skin |
|
|
249 | |
|
|
249 | |
|
3.2.2 Wound Healing and Angiogenesis |
|
|
250 | |
|
3.3 Gene-enhanced Tissue-Engineered Skin: A Transplantable Bioreactor for Treatment of Systemic Disorders |
|
|
255 | |
|
3.4 Future Developments for Efficient Gene Transfer |
|
|
258 | |
|
3.4.1 Gene Transfer to Epidermal Stem Cells |
|
|
258 | |
|
3.4.2 Regulatable Gene Therapy |
|
|
259 | |
|
4 Gene-Modified Skin Substitutes as Biological Models of Tissue Development and Disease Pathophysiology |
|
|
261 | |
|
|
263 | |
|
|
264 | |
Nanostructured Biomaterials for Tissue Engineering Bone |
|
|
|
275 | |
|
|
276 | |
|
1.1 Nanotechnology and Bone Tissue Engineering |
|
|
276 | |
|
1.2 Bone: A Nanostructured Biomaterial |
|
|
278 | |
|
1.3 Clinical Need for Better Orthopedic Implant Materials |
|
|
279 | |
|
1.3.1 Metallic Implants: Mechanical Stabilization During Skeletal Reconstruction |
|
|
280 | |
|
1.3.2 Autograft and Allograft: Bone Regeneration During Skeletal Reconstruction |
|
|
282 | |
|
1.4 Nanostructured Tissue Engineered Synthetic Bone |
|
|
284 | |
|
2 Properties of Nanostructured Tissue Engineered Synthetic Bone |
|
|
284 | |
|
|
284 | |
|
2.2 Mechanical Properties |
|
|
285 | |
|
2.2.1 Effect of Defect Size |
|
|
286 | |
|
2.2.2 The Effect of Fracture Toughness |
|
|
288 | |
|
|
289 | |
|
2.3.1 Effect of Nanostructured Surfaces on Protein Interactions |
|
|
289 | |
|
2.3.2 The Effect of Nanostructured Surfaces on Cellular Interactions |
|
|
299 | |
|
3 Unassesed Risks of Using Nanophase Particles as Implantable Materials |
|
|
303 | |
|
|
303 | |
|
|
305 | |
Integration of Technologies for Hepatic Tissue Engineering |
|
|
Y. Nahmias, F. Berthiaume, M.L. Yarmush |
|
|
309 | |
|
|
310 | |
|
2 Liver Development and Biology |
|
|
310 | |
|
3 Maintenance of Liver Tissue Ex Vivo |
|
|
313 | |
|
4 Hepatocyte Culture Techniques |
|
|
314 | |
|
5 Hepatic Heterotypic Interactions |
|
|
316 | |
|
6 Role of Oxygen in Hepatocyte Culture |
|
|
319 | |
|
7 Impact of Culture Medium Formulation |
|
|
320 | |
|
|
321 | |
|
9 Current Challenges and Opportunities |
|
|
323 | |
|
|
325 | |
Author Index Volumes 100-103 |
|
331 | |
Subject Index |
|
333 | |